Wiviott, Stephen D2; White, Harvey D3; Ohman, E Magnus3; Fox, Keith A A3; Armstrong, Paul W3; Prabhakaran, Dorairaj3; Hafley, Gail3; Lokhnygina, Yuliya3; Boden, William E3; Hamm, Christian3; Clemmensen, Peter1; Nicolau, Jose C3; Menozzi, Alberto3; Ruzyllo, Witold3; Widimsky, Petr3; Oto, Ali3; Leiva-Pons, Jose3; Pavlides, Gregory3; Winters, Kenneth J3; Roe, Matthew T3; Bhatt, Deepak L3
1 Hjertemedicinsk Klinik, Hjertecentret Rigshospitalet, Rigshospitalet, The Capital Region of Denmark2 Brigham and Women's Hospital and Harvard Medical School3 unknown
a secondary, prespecified analysis of the TRILOGY ACS trial
Treatment with prasugrel and aspirin improves outcomes compared with clopidogrel and aspirin for patients with acute coronary syndrome who have had angiography and percutaneous coronary intervention; however, no clear benefit has been shown for patients managed first with drugs only. We assessed outcomes from the TRILOGY ACS trial based on whether or not patients had coronary angiography before treatment was chosen.